scholarly journals Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases

1998 ◽  
Vol 64 (6) ◽  
pp. 751-757 ◽  
Author(s):  
S. Jitpimolmard ◽  
S. Tiamkao ◽  
M. Laopaiboon
Keyword(s):  
Botulinum Toxin ◽  
Hemifacial Spasm ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Long Term Results

Long-term treatment with botulinum toxin type A in hemifacial spasm

Toxicon ◽  
2008 ◽  
Vol 51 ◽  
pp. 30-31
Author(s):  
Kollewe Katja ◽  
Krampfl Klaus ◽  
Bigalke Hans ◽  
Dengler Reinahrd ◽  
Mohammadi Bahram
Keyword(s):  
Botulinum Toxin ◽  
Hemifacial Spasm ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Term Treatment ◽  
Long Term Treatment

Long-term results of botulinum toxin type A in complex abdominal wall repair and review of the literature

2020 ◽  
Vol 72 (4) ◽  
pp. 1201-1206 ◽  
Author(s):  
Vanesa Catalán-Garza ◽  
María Jesús Peña-Soria ◽  
Patricia Sáez-Carlin ◽  
Juan Jesús Cabeza-Gómez ◽  
Andrés García-Fernández ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Abdominal Wall ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Long Term Results ◽  
Review Of The Literature ◽  
Abdominal Wall Repair

scholarly journals Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience

2010 ◽  
Vol 68 (4) ◽  
pp. 502-505 ◽  
Author(s):  
Egberto Reis Barbosa ◽  
Leonel Tadao Takada ◽  
Lilian Regina Gonçalves ◽  
Rose Mary Paulo do Nascimento Costa ◽  
Laura Silveira-Moriyama ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Hemifacial Spasm ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
School Of Medicine ◽  
Long Term Effect ◽  
Subjective Judgement ◽  
The Mean

In order to evaluate the long-term effect of botulinum toxin type A (BTX) in the treatment of hemifacial spasm (HFS), a retrospective analysis of patients treated at the Movement Disorders Unit of the Division of Neurology, Clinical Hospital, University of São Paulo, School of Medicine from 1993 to 2004 was made. A total of 808 injections with BTX were administered to 54 patients with HFS. The mean duration of improvement per application was 3.46 months and the mean rate of improvement using subjective judgement by the patient was of 83%. Adverse effects, mostly minor, were observed in 64.8% of patients at least once along the period of follow-up and the most frequent of them was orbicularis oris paralysis (38.8%). There was no decrement in response when compared the first and the last injection recorded.

scholarly journals Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated

2017 ◽  
Vol 75 (2) ◽  
pp. 87-91 ◽  
Author(s):  
Jean Pierre Mette Batisti ◽  
Alais Daiane Fadini Kleinfelder ◽  
Natália Bassalobre Galli ◽  
Adriana Moro ◽  
Renato Puppi Munhoz ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Side Effects ◽  
Hemifacial Spasm ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Term Effect ◽  
Long Term Effect

ABSTRACT Hemifacial spasm (HFS) is a common movement disorder characterized by involuntary tonic or clonic contractions of the muscles innervated by the facial nerve. Objective To evaluate the long-term effect of botulinum toxin type A (BTX-A) in the treatment of HFS. Methods A retrospective analysis of patients treated at the Movement Disorders Outpatient Clinic in the Neurology Service, Hospital de Clínicas, Federal University of Paraná, Curitiba, from 2009 to 2013 was carried out. A total of 550 BTX-A injections were administered to 100 HFS patients. Results Mean duration of improvement following each injection session was 3.1 months, mean latency to detection of improvement was 7.1 days and mean success rate was 94.7%. Patients were evaluated at an interval of 5.8 months after each application. Adverse effects, which were mostly minor, were observed in 37% of the patients at least once during follow-up. The most frequent was ptosis (35.1%). Conclusion Treatment of HFS with BTX-A was effective, sustainable and safe and had minimal, well-tolerated side effects.

scholarly journals Long-term Safety and Efficacy Data on Botulinum Toxin Type A

2013 ◽  
Vol 139 (2) ◽  
pp. 134 ◽  
Author(s):  
Kenny H. Chan ◽  
Conan Liang ◽  
Pamela Wilson ◽  
David Higgins ◽  
Gregory C. Allen
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Efficacy Data ◽  
Safety And Efficacy

scholarly journals Botulinum toxin type A therapy for hemifacial spasm

2020 ◽  
Author(s):  
Gonçalo S Duarte ◽  
Filipe B Rodrigues ◽  
Mafalda Castelão ◽  
Raquel E Marques ◽  
Joaquim Ferreira ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Hemifacial Spasm ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type

Long-term efficacy and safety of a new botulinum toxin type A preparation in mouse gastrocnemius muscle

Toxicon ◽  
2020 ◽  
Vol 187 ◽  
pp. 163-170
Author(s):  
Jungtae Na ◽  
Esther Lee ◽  
Yu-jin Kim ◽  
Mi Ji Choi ◽  
Su-Young Kim ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Gastrocnemius Muscle ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Efficacy And Safety ◽  
Term Efficacy
Sign in / Sign up

Export Citation Format

Share Document